Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00391651 · ClinicalTrials.gov registry record · Phase 2
Short Course Nitrofurantoin for Acute Cystitis
A Phase 2 study of Urinary Tract Infection, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 338
- Enrollment target
- 1
- Study location
NCT00391651 is a Phase 2 study of Urinary Tract Infection that has completed, run by University of Washington. The registered enrollment target is 338 participants, below the 643-participant average among 11 other Urinary Tract Infection trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00391651, a Phase 2 study of Urinary Tract Infection, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 338 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to determine what the cure rates are with a 5 day course of nitrofurantoin versus the more standard 3 day course of trimethoprim/sulfamethoxazone. The study will improve our knowledge of which antibiotic and what length of therapy is best for treatment of UTI, taking into account the problem of antibiotic resistance. Procedures subjects will undergo once they have read and signed the consent are: Questions about their medical and sexual history and current symptoms of UTI. They will be asked to provide a urine sample and then randomly assigned to one of the two treatment groups. will be obtained at each visit. If they were assigned to the nitrofurantoin treatment regimen, they will also be asked to collect a urine sample at home on the third day. If the subject develops recurrent urinary symptoms or does not have resolution of symptoms after completing the initial treatment course, they will be asked to return to the clinic and provide another urine sample for analysis. They will then be treated with another standard antibiotic at no cost to them and will be withdrawn from the study at that time. The study population is women ages 18-45 with acute symptoms of a UTI without a history of UTI in the past 6 weeks.
Conditions Studied
Interventions
- DRUG Nitrofurantoin 100mg twice daily x 5 days
- DRUG TMP/SMX DS twice daily x 3 days
Study Locations (1)
Washington
- University of WA - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2002-01 |
| Est. Completion | 2005-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00391651
The ClinicalTrials.gov registry entry for NCT00391651 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 338 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 643-participant average among 11 other Urinary Tract Infection trials with a reported enrollment target (47% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Urinary Tract Infection appearing as the primary indexed condition, and to 2 interventions - of which Nitrofurantoin 100mg twice daily x 5 days is the first listed.
NCT00391651 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT00391651 about?
NCT00391651 is a clinical study titled "Short Course Nitrofurantoin for Acute Cystitis". The purpose of this research study is to determine what the cure rates are with a 5 day course of nitrofurantoin versus the more standard 3 day course of trimethoprim/sulfamethoxazone. The study will improve our knowledge of which antibiotic and what length of therapy is best for treatment of UTI, t...
What is the current status of trial NCT00391651?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 338 participants. The study started on 2002-01. Estimated completion is 2005-07.
What conditions does trial NCT00391651 study?
This clinical trial studies the following conditions: Urinary Tract Infection.
What interventions are being tested in trial NCT00391651?
The interventions under investigation include: Nitrofurantoin 100mg twice daily x 5 days (DRUG), TMP/SMX DS twice daily x 3 days (DRUG).
Who is sponsoring clinical trial NCT00391651?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00391651 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preventing Urinary Tract Infection Post-Surgery
COMPLETED · Phase 2
-
A Randomized Control Trial Comparing Single vs. Multiple Application of Lidocaine Analgesia Prior to Urethral Catheterization Procedures
COMPLETED · Phase 2
-
The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.
RECRUITING · NA
-
Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
RECRUITING · NA
-
Cefpodoxime vs Ciprofloxacin for Acute Cystitis
COMPLETED · NA
-
ParentLink: Better and Safer Emergency Care for Children
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.